AI Analysis AI Analysis of GSK AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add GSK to Watchlist?
Some Reasons Why To Add GSK:
  • Beat earnings estimates in all of the last 4 quarters
  • Excellent financial health (Piotroski 7/9)
  • High gross margin of 72.7%
PDF

Evaluation of GlaxoSmithKline stock downgraded after the last trading session
(Updated on Jul 13, 2026)

Buy or Hold candidate since Jun 23, 2026 Gain 0.42%

The GlaxoSmithKline stock price fell by -0.93% on the last day (Monday, 13th Jul 2026) from $52.78 to $52.29. During the last trading day the stock fluctuated 1.80% from a day low at $51.75 to a day high of $52.68. The price has fallen in 6 of the last 10 days and is down by -0.4% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -978 thousand shares and in total, 2 million shares were bought and sold for approximately $98.82 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.08% during the next 3 months and, with a 90% probability hold a price between $45.25 and $53.32 at the end of this 3-month period.

GSK Signals & Forecast

The GlaxoSmithKline stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $52.88. On a fall, the stock will find some support from the long-term average at approximately $51.71. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 6.71%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for GlaxoSmithKline stock

GlaxoSmithKline finds support from accumulated volume at $51.40 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.93 between high and low, or 1.80%. For the last week the stock has had daily average volatility of 1.50%.

Our recommended stop-loss: $49.72 (-4.92%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 27 days ago.)

Trading Expectations (GSK) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect GlaxoSmithKline PLC to open at $52.24, and during the day (based on 14 day Average True Range), to move between $51.74 and $52.84, which gives a possible trading interval of +/-$1.10 (+/-2.13%) up or down from last closing price. If GlaxoSmithKline PLC takes out the full calculated possible swing range there will be an estimated 2.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $52.31 (0.04%) than the support at $51.40 (1.70%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is GlaxoSmithKline PLC stock A Buy?

GlaxoSmithKline holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.428 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $52.24 ( 0.0956%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

GSK Performance

Trading levels for GSK

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 53.17 1.68%
R2 52.81 1.00%
R1 52.60 0.584%
Price 52.29
S1 51.88 -0.775%
S2 51.67 -1.19%
S3 51.31 -1.87%

Accumulated Volume Support & Resistance Levels

Level Price
R3 54.47 4.17%
R2 54.44 4.11%
R1 52.31 0.0382%
Price 52.29
S1 51.40 -1.70%
S2 51.25 -1.99%
S3 50.90 -2.66%

GSK Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Apr 29, 2026 May 15, 2026 Jul 09, 2026 $0.0100 0.0194%
2 Feb 20, 2026 Feb 20, 2026 Apr 09, 2026 $0.486 0.82%
3 Nov 14, 2025 Nov 14, 2025 Jan 08, 2026 $0.410 0.87%
4 Aug 15, 2025 Aug 15, 2025 Oct 09, 2025 $0.421 1.13%
5 May 16, 2025 May 16, 2025 Jul 10, 2025 $0.422 1.10%

FAQ

What is the symbol for GlaxoSmithKline Stock and on which exchange is it traded?
The symbol for GlaxoSmithKline is GSK and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell GlaxoSmithKline Stock?
GlaxoSmithKline holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy GlaxoSmithKline Stock?
GlaxoSmithKline Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy GlaxoSmithKline Stock.

What's the current price of GlaxoSmithKline Stock?
As of the end of day on the Jul 13, 2026, the price of an GlaxoSmithKline (GSK) share was $52.29.

What is the 52-week high and low for GlaxoSmithKline Stock?
The 52-week high for GlaxoSmithKline Stock is $61.70 and the 52-week low is $35.47.

What is the market capitalization of GlaxoSmithKline Stock?
As of the Jul 13, 2026, the market capitalization of GlaxoSmithKline is 104.726B.

When is the next earnings date for GlaxoSmithKline?
The upcoming earnings date for GlaxoSmithKline is Jul 28, 2026.
Click to get the best stock tips daily for free!
ABOUT GLAXOSMITHKLINE PLC
GlaxoSmithKline
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medic...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE